The Risks of Dangerous Research

Should research that makes pathogens more deadly or infectious—or other dangerous research—be conducted in the first place?

Written byTia Ghose
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Electron micrograph of avian influenzaCDC

In the wake of news last month that researchers had created a version of the deadly bird flu that was easily transmissible by air, a heated debate has arisen in the scientific community about whether or not the research should be published. But some experts are taking the discussion a step further back, and wondering why the research was conducted at all.

“Why should our tax dollars be used to create new pandemic pathogens?” said Richard Ebright, a chemical biologist at Rutgers University.

The bird flu breakthrough came from two separate groups, one at Erasmus University in the Netherlands and another at the University of Wisconsin, Madison, who successfully converted H5N1 into a form that can be transmitted between ferrets in droplets through the air. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies